Wednesday, February 18


Hyderabad: From being known as the city of Charminar, biryani, pharma manufacturing and software, in just two and a half decades Hyderabad has rapidly grown to emerge as a preferred destination for life sciences companies to set up global capability centres (GCCs), build innovation engines, design molecules and drugs, manage clinical analytics, build AI platforms and drive digital manufacturing, chief minister A Revanth Reddy said on Tuesday.Telangana’s “strong vision and clear policy”, deep talent pool and strong educational institutions have driven the state to one of the top life sciences hubs globally, with investments of around Rs 73,000 crore attracted in the past couple of years alone, the CM said while inaugurating the 23rd edition of BioAsia here on the theme ‘TechBio Unleashed.’Describing Hyderabad as a “trusted, stable, and future-ready ecosystem”, Revanth said Telangana is moving up the value chain “from bulk drugs to biologics” and from manufacturing to innovation.Pointing to the scale of international participation at BioAsia, the CM said Asia’s largest life sciences platform could soon be renamed BioWorld, a global platform for the life sciences sector with recognition akin to the World Economic Forum that is organised at Davos.Industries and IT minister D Sridhar Babu said Telangana aims to develop Hyderabad as a “laboratory of the future”, targeting $25 billion in life sciences investments and 5 lakh new jobs by 2030.He invited global enterprises and investors to partner with Telangana, which offers opportunities across AI-based drug discovery, automation in biologics manufacturing, data-driven precision medicine, computational biology and Bio-Manufacturing 4.0.Pointing out that India is no longer viewed merely as a supply base for pharmaceuticals and vaccines but is increasingly being seen as a source of advanced scientific solutions, Sridhar Babu said, “Telangana is preparing for this shift — from a manufacturing base to a global centre for innovation, research and advanced drug discovery.”He said the Next-Gen Life Sciences Policy (2026–2030) is designed to place Telangana among the world’s top three life sciences clusters by the end of this decade. He also pointed to Hyderabad’s inclusion in the CBRE Global Life Sciences Atlas (2025) alongside hubs such as Boston, San Francisco, Beijing and Tokyo.The minister also said the state is beefing up its research, innovation and high-end manufacturing ecosystem through structured interventions that include building a future-ready workforce through institutions such as the Telangana School of Life Sciences and Young India Skills University, which will provide specialised training in emerging domains including mRNA technology, gene editing and AI-driven drug discovery.The minister said a dedicated policy is also introduced to develop Hyderabad as a global medical tourism hub.



Source link

Share.
Leave A Reply

Exit mobile version